about
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, ...
Read More
47.85
-0.02
(-0.04%)
175.2K
XNAS Volume
XNAS 03 Oct, 2025 1:26 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Tourmaline Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..